Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,104 public trials 618 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Recruiting

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

NCT06652438

Conditions: Acute Myeloid Leukemia, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: DE-Berlin-CAMPUSBENFRANKLIN Berlin, Germany

DE-Berlin-CAMPUSVIRCHOW Berlin, Germany

DE-Berlin-VIVANTESNEUKOLLN Berlin, Germany

DE-Bochum-RUB Bochum, Germany

View all 67 locations

View Trial Details

Recruiting

The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors

NCT06911710

Conditions: AML (Acute Myelogenous Leukemia), B-ALL, Blood Protein Disorders, +23 more
Locations: TianJin China. TianJin Medical University General Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Gut Health in Children With Cancer

NCT06899581

Conditions: AML (Acute Myelogenous Leukemia, Burkitt Lymphoma, Burkitt Lymphoma/Leukemia, +21 more
Locations: Great Ormond Street Hospital London, United Kingdom

View Trial Details

Recruiting

Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid Leukemia

NCT05282108

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +13 more
Locations: National Cancer Institute (NCI) Cairo, Egypt

Ain Shams University Hospital Cairo, Egypt

Nasser Institute Cairo, Egypt

Tanta Oncology Center Tanta, Egypt

View Trial Details

Recruiting

Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation

NCT06892223

Conditions: Acute Myeloid Leukaemia, Anemia, Anemia, Refractory, +13 more
Locations: IRCCS Ospedale Policlinico San Martino Genova, GENOVA, Italy

Irccs Istituto Clinico Humanitas Rozzano, MILANO, Italy

View Trial Details

Recruiting

Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia

NCT06022003

Conditions: AML, Adult, FLT3-ITD, FLT3-TKD Mutation, +9 more
Locations: Amiens CHU Amiens, France

Angers CHU Angers, France

Hôpital d'Instruction des Armées PERCY Clamart, France

CHU Estaing Clermont-Ferrand, France

View all 20 locations

View Trial Details

Recruiting

Epidemiological Study of a Prospective Cohort of Patients Aged 60 and Over Managed for Acute Myeloid Leukemia (AML) and Receiving Intensive Induction Therapy

NCT06891144

Conditions: AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Angers CHU Angers, France

Annecy CH Annecy, France

Avignon CH Avignon, France

Bayonne CH Bayonne, France

View all 27 locations

View Trial Details

Recruiting

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

NCT06245746

Conditions: Acute Myeloid Leukemia, Agranulocytosis, Anemia, +18 more
Locations: Wuhan Union Hospital Wuhan, Hubei, China

View Trial Details

Recruiting

Infusion of Alloreactive nk Cells for Mrd-positive Aml Patients

NCT06885476

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations: Antonio Curti Bologna, BO, Italy

View Trial Details

Recruiting

A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)

NCT05947344

Conditions: AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: the First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Leukemia, Myeloid

Leukemia, Myeloid trial results

Related conditions